Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Alzheimer    symbols : IGC    save search

Phase 1 Clinical Trial Data Indicate IGC’s THC-based Investigational New Drug May Reduce Symptoms of Dementia in Alzheimer’s Patients
Published: 2021-12-02 (Crawled : 15:30) - igcinc.us
IGC 4 | $0.439 -3.86% 1.78% 430K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 23.81% C: -0.79%

new drug alzheimer dementia drug trial phase 1 phase 2 alzheimer’s alzheimer's
IGC Completes its Phase 1 Clinical Trial on Alzheimer’s Patients, Reports Safety and Tolerability
Published: 2021-09-08 (Crawled : 14:00) - igcinc.us
IGC 4 | $0.439 -3.86% 1.78% 430K twitter stocktwits trandingview |
Health Technology
| | O: 6.92% H: 1.76% C: -7.06%

alzheimer phase 1 trial phase 2 phase 3 alzheimer’s alzheimer's
IGC Announces Issuance of Patent for the Treatment of Alzheimer’s Disease Using THC
Published: 2021-07-22 (Crawled : 16:00) - igcinc.us
IGC 4 | $0.439 -3.86% 1.78% 430K twitter stocktwits trandingview |
Health Technology
| | O: 165.54% H: 18.32% C: -28.75%

disease alzheimer treatment patent alzheimer’s alzheimer's disease alzheimer's
IGC Completes the Final Cohort of its Phase 1 Clinical Trial on Alzheimer’s Patients
Published: 2021-06-24 (Crawled : 01:00) - igcinc.us
IGC 4 | $0.439 -3.86% 1.78% 430K twitter stocktwits trandingview |
Health Technology
| | O: 17.57% H: 9.2% C: -5.17%

alzheimer phase 1 trial phase 2 phase 3 alzheimer’s alzheimer's
IGC Completes Cohort 2 of its Phase 1 THC-Based Clinical Trial on Alzheimer’s Patients
Published: 2021-06-09 (Crawled : 18:00) - igcinc.us
IGC 4 | $0.439 -3.86% 1.78% 430K twitter stocktwits trandingview |
Health Technology
| | O: 0.64% H: 1.9% C: -5.7%

alzheimer phase 1 trial phase 3 phase 2 alzheimer’s alzheimer's
IGC Completes Cohort 1 of its Phase 1 THC-Based Clinical Trial on Alzheimer’s Patients
Published: 2021-05-14 (Crawled : 14:00) - igcinc.us
IGC 4 | $0.439 -3.86% 1.78% 430K twitter stocktwits trandingview |
Health Technology
| | O: 8.0% H: 3.7% C: 1.48%

alzheimer phase 1 trial phase 3 phase 2 alzheimer’s alzheimer's
Gainers vs Losers
62% 38%

Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M twitter stocktwits trandingview |
Consumer Services

BOF | $1.99 70.09% 41.21% 110M twitter stocktwits trandingview |

ILAG | $0.51 6.03% 40.62% 1.7M twitter stocktwits trandingview |

LICN | $0.941 68.04% 40.49% 15M twitter stocktwits trandingview |

AMST | $3.31 65.5% 39.58% 70M twitter stocktwits trandingview |
Technology Services

MTC | $3.615 61.38% 38.04% 9.3M twitter stocktwits trandingview |
Technology Services

WIMI | $1.15 58.53% 36.92% 19M twitter stocktwits trandingview |
Technology Services

AIH | $0.45 12.5% 30.92% 320K twitter stocktwits trandingview |
Health Services

MULN | News | $3.78 38.46% 27.78% 13M twitter stocktwits trandingview |
Information

RILY | $29.86 37.48% 27.26% 12M twitter stocktwits trandingview |
Finance


Your saved searches
Save your searches and get alerts when important news are released.